Virtual Brain Modelling Reveals Altered Network Dynamics and Predicts Symptom Severity in Schizophrenia: Relevance to Antipsychotic Treatment Response and Resistance.
- 1University of Pavia
Abstract
Background: Schizophrenia (SZ) is a heterogeneous disorder characterized by positive, negative, cognitive and disorganisation symptoms, with pleomorphic phenotype and poorly understood aetiology. Dopamine dysregulation represents the most replicated in vivo pathophysiology finding. However, accumulating evidence suggests altered large-scale brain connectivity and excitation/inhibition balance disruption. While quantifying these alterations would help clarify SZ neurophysiology and guide therapy, single-patient identification remains impractical. This is particularly relevant for treatment-resistant SZ (TRS) whose pathophysiology remains unclear. Methods: Using virtual brain modelling, we simulated large-scale brain dynamics from functional and structural MRI data in 43 healthy controls and 33 SZ patients, stratified into TRS and non-TRS. We used the Wong-Wang model to derive four network parameters reflecting GABAergic and NMDA receptor-mediated glutamatergic transmission: global coupling (G), local inhibitory (Ji) and excitatory (JNMDA) coupling, and recurrent excitation (w+). We performed simulations in the whole brain and in resting-state networks, compared model parameters between groups and tested their association with Positive and Negative Syndrome Scale (PANSS) scores. Results: Compared to non-TRS, TRS patients showed increased JNMDA and decreased w+ at the whole-brain level, increased JNMDA and G in the dorsal attention network, lower G in the limbic network and increased w+ in the visual network. Moreover, Ji in the default mode network predicted negative symptom severity while JNMDA in the limbic and ventral attention networks predicted total PANSS scores and disorganisation. Conclusions: These findings suggest that TRS is characterized by network-specific alterations in excitation/inhibition profiles and support the use of personalised multiscale modelling to identify symptom biomarkers.
Related
- Modelling the role of the microbiome in antimicrobial resistance across scales
- Storage-Dependent Responses of KDML 105 Rice (Oryza sativa L.) Seeds Across Dynamic Magnetic-Field Treatment Conditions: Germination, Seedling Growth, and Dual-Phase Hydration Modelling
- Modelling impacts of paediatric amoxicillin shortage management on pneumococcal resistance and invasive disease in Europe
- A multiscale pharmacokinetic-Boolean modelling framework for ibrutinib resistance in a Chronic Lymphocytic Leukaemia case study
- Regional and network-level resting state functional connectivity markers of pharmacological treatment resistance in obsessive-compulsive disorder
BibTeX
@misc{vitacca2026virtual,
title = {{Virtual Brain Modelling Reveals Altered Network Dynamics and Predicts Symptom Severity in Schizophrenia: Relevance to Antipsychotic Treatment Response and Resistance.}},
author = {M. Vitacca and D. Pischedda and M. Ciccarelli and G. Pontillo and G. De Simone and S. Cocozza and F. Cipranic and A. Monteverdi and P. Fusar-Poli and C. A. M. Gandini Wheeler-Kingshott and F. Palesi and A. de Bartolomeis and E. D'Angelo},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.13.758782},
url = {https://www.biorxiv.org/content/10.64898/2026.10.13.758782v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Virtual Brain Modelling Reveals Altered Network Dynamics and Predicts Symptom Severity in Schizophrenia: Relevance to Antipsychotic Treatment Response and Resistance.
AU - M. Vitacca
AU - D. Pischedda
AU - M. Ciccarelli
AU - G. Pontillo
AU - G. De Simone
AU - S. Cocozza
AU - F. Cipranic
AU - A. Monteverdi
AU - P. Fusar-Poli
AU - C. A. M. Gandini Wheeler-Kingshott
AU - F. Palesi
AU - A. de Bartolomeis
AU - E. D'Angelo
PY - 2026
DA - 2026/10/13
PB - bioRxiv
DO - 10.64898/2026.10.13.758782
UR - https://www.biorxiv.org/content/10.64898/2026.10.13.758782v1
AB - Background: Schizophrenia (SZ) is a heterogeneous disorder characterized by positive, negative, cognitive and disorganisation symptoms, with pleomorphic phenotype and poorly understood aetiology. Dopamine dysregulation represents the most replicated in vivo pathophysiology finding. However, accumulating evidence suggests altered large-scale brain connectivity and excitation/inhibition balance disruption. While quantifying these alterations would help clarify SZ neurophysiology and guide therapy, single-patient identification remains impractical. This is particularly relevant for treatment-resistant SZ (TRS) whose pathophysiology remains unclear. Methods: Using virtual brain modelling, we simulated large-scale brain dynamics from functional and structural MRI data in 43 healthy controls and 33 SZ patients, stratified into TRS and non-TRS. We used the Wong-Wang model to derive four network parameters reflecting GABAergic and NMDA receptor-mediated glutamatergic transmission: global coupling (G), local inhibitory (Ji) and excitatory (JNMDA) coupling, and recurrent excitation (w+). We performed simulations in the whole brain and in resting-state networks, compared model parameters between groups and tested their association with Positive and Negative Syndrome Scale (PANSS) scores. Results: Compared to non-TRS, TRS patients showed increased JNMDA and decreased w+ at the whole-brain level, increased JNMDA and G in the dorsal attention network, lower G in the limbic network and increased w+ in the visual network. Moreover, Ji in the default mode network predicted negative symptom severity while JNMDA in the limbic and ventral attention networks predicted total PANSS scores and disorganisation. Conclusions: These findings suggest that TRS is characterized by network-specific alterations in excitation/inhibition profiles and support the use of personalised multiscale modelling to identify symptom biomarkers.
ER -